Clinical Trials in Nashville

Showing 2481-2500 of 17,403 trials

A Study to Evaluate AI-09 In Participants With Glabellar Lines

NCT07321834

Phase 2 clinical study to evaluate the efficacy, safety, and tolerability of AI-09, a Ready-to-Use Liquid Injectable Botulinum Toxin.

Glabellar Lines

Eirion Therapeutics Inc.68 participantsStarted Dec 2025

Aventura, Florida, United States • West Palm Beach, Florida, United States • New Orleans, Louisiana, United States +2 more locations

Active Not RecruitingPhase 1< 1 mile

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

NCT05006794

This is a Phase I open-label, multi-center study of zamzetoclax (formerly GS-9716) tested either as monotherapy or in combination with other anti-cancer agents in patients with advanced solid malignancies. Primary objectives are to define the maximum tolerated dose (MTD) or maximum administered dose of zamzetoclax, and characterize the safety and tolerability of zamzetoclax as monotherapy and in combination with anti-cancer therapies.

Solid Malignancies

Gilead Sciences145 participantsStarted Sep 2021

Aurora, Colorado, United States • Tampa, Florida, United States • Grand Rapids, Michigan, United States +10 more locations

A Study to Evaluate AI-09 In Participants With Glabellar Lines

Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GS-9716 as Monotherapy and in Combination With Anticancer Therapies in Adults With Solid Malignancies

Find Trials by Condition in Nashville

Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS

The PLATINUM Trial: Optimizing Chemotherapy for the Second-Line Treatment of Metastatic BRCA1/2 or PALB2-Associated Metastatic Pancreatic Cancer

Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy

A Study of Disitamab Vedotin Alone or With Pembrolizumab in Urothelial Cancer That Expresses HER2

Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS)

A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus

Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)

DECIDE: A Comparative Effectiveness Trial of Metformin Versus Insulin for the Treatment of Gestational Diabetes

A Study to Evaluate the Efficacy, Safety, and Tolerability of ASC30 Tablets in Participants With Type 2 Diabetes Mellitus

Molgramostim Nebulizer Solution Expanded Access Program Protocol

[18F]PI-2620 Phase 3 Histopathological Study

A Phase 1/2 Study of NRTX-1001 Neuronal Cell Therapy in Drug-Resistant Bilateral Mesial Temporal Lobe Epilepsy (MTLE)

CD40-L Blockade for Prevention of Acute Graft-Versus-Host Disease

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

First-in-Human, Phase I, Open-label, Multicenter, Dose Escalation Clinical Study

International Registry of Intra-arterial and Endosaccular Flow Diverters (IRF)

A Phase 1b Study of Budoprutug in Systemic Lupus Erythematosus (SLE)

Roll-over Study for Patients Who Have Completed a Prior Novartis-sponsored Sabatolimab (MBG453) Study and Are Judged by the Investigator to Benefit From Continued Treatment With Sabatolimab.